Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kent

Showing results (71-80 of 268) with videos related to

Pageof 27
Sort By:
Health Affairs (Project Hope)|November 15, 2005
Reporting clinical trial results to inform providers, payers, and consumersRodney A Hayward, David M Kent, Sandeep Vijan, et al.
The Journal of Pediatrics|June 30, 2018
Population-Based Validation of a Clinical Prediction Model for Congenital Diaphragmatic HerniasDaniel P Bent, Jason Nelson, David M Kent, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Estimating the Risk-Based Value of the Diabetes Prevention Program: How well does clinical trial-based cost-effectiveness apply to the real world?Natalia Olchanski, Samuel B Weidner, Ching-Hsuan Lin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Assessing heterogeneity of treatment effect in multiple sclerosis trialsMaria Pia Sormani, Jeremy Chataway, David M Kent, et al.
Statistics in Medicine|October 13, 2023
Measuring the performance of prediction models to personalize treatment choice: Defining observed and predicted pairwise treatment effectsDavid van Klaveren, Carolien C H M Maas, David M Kent
Journal of General Internal Medicine|December 11, 2002
Is primary angioplasty for some as good as primary angioplasty for all?David M Kent, Christopher H Schmid, Joseph Lau, et al.
Diagnostic and Prognostic Research|May 27, 2020
When predictions are used to allocate scarce health care resources: three considerations for models in the era of Covid-19David M Kent, Jessica K Paulus, Richard R Sharp, et al.
Epidemiology (Cambridge, Mass.)|October 7, 2010
Accounting for center effects in multicenter trialsNavdeep Tangri, Georgios D Kitsios, Shi Hann Su, et al.
Annals of Internal Medicine|August 8, 2018
Risk-Targeted Lung Cancer ScreeningVaibhav Kumar, Joshua T Cohen, Peter J Neumann, et al.
Annals of Internal Medicine|November 4, 2009
Much cheaper, almost as good: decrementally cost-effective medical innovationAaron L Nelson, Joshua T Cohen, Dan Greenberg, et al.
Pageof 27

Showing results (71-80 of 268) with videos related to

Sort By:
Pageof 27
Health Affairs (Project Hope)|November 15, 2005
Reporting clinical trial results to inform providers, payers, and consumersRodney A Hayward, David M Kent, Sandeep Vijan, et al.
The Journal of Pediatrics|June 30, 2018
Population-Based Validation of a Clinical Prediction Model for Congenital Diaphragmatic HerniasDaniel P Bent, Jason Nelson, David M Kent, et al.
Medrxiv : the Preprint Server for Health Sciences|December 8, 2025
Estimating the Risk-Based Value of the Diabetes Prevention Program: How well does clinical trial-based cost-effectiveness apply to the real world?Natalia Olchanski, Samuel B Weidner, Ching-Hsuan Lin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Assessing heterogeneity of treatment effect in multiple sclerosis trialsMaria Pia Sormani, Jeremy Chataway, David M Kent, et al.
Statistics in Medicine|October 13, 2023
Measuring the performance of prediction models to personalize treatment choice: Defining observed and predicted pairwise treatment effectsDavid van Klaveren, Carolien C H M Maas, David M Kent
Journal of General Internal Medicine|December 11, 2002
Is primary angioplasty for some as good as primary angioplasty for all?David M Kent, Christopher H Schmid, Joseph Lau, et al.
Diagnostic and Prognostic Research|May 27, 2020
When predictions are used to allocate scarce health care resources: three considerations for models in the era of Covid-19David M Kent, Jessica K Paulus, Richard R Sharp, et al.
Epidemiology (Cambridge, Mass.)|October 7, 2010
Accounting for center effects in multicenter trialsNavdeep Tangri, Georgios D Kitsios, Shi Hann Su, et al.
Annals of Internal Medicine|August 8, 2018
Risk-Targeted Lung Cancer ScreeningVaibhav Kumar, Joshua T Cohen, Peter J Neumann, et al.
Annals of Internal Medicine|November 4, 2009
Much cheaper, almost as good: decrementally cost-effective medical innovationAaron L Nelson, Joshua T Cohen, Dan Greenberg, et al.
Pageof 27